According to tthe new statistics, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6 % of […]
Follow Us
-
+1 700 888 1234
-
Effingerstrasse 40 3008 Bern Switzerland
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
According to tthe new statistics, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6 % of […]
During the congress, one of the topics covered focused on the importance of EGFR TKIs in Advanced NSCLC. Apply expert […]
During the World Congress on Lung Cancer held this year in Toronto, Canada were presented the findings of NELSON study. […]
Starting September, Alfonso Aguarón (second from left) is LuCE’s new project manager. He has extensive experience in patient advocacy field […]
A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by […]
Due to the distinct features of cancer immunotherapy, and rapid progress in the field, clinical guidance is needed on the […]
The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through […]
ECCO and its members have now set out a manifesto for improved access to innovation in a consensus paper published in […]
LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD […]
Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment […]
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
